Singapore, April 9 -- To meet growing demand from the pharmaceutical industry, Japan-based Asahi Kasei has established Asahi Kasei Life Science to operate its bioprocess businesses under a new organisational structure. Through this change, the company can offer the industry more agile and focused services, deeper innovation in bioprocess solutions, and stronger support in emerging modalities.

As part of the evolving pharmaceutical ecosystem, where multiple stakeholders are involved in drug development and manufacturing, Asahi Kasei's bioprocess-related business units have operated under Asahi Kasei Life Science since April 1stof this year.

This includes virus removal filters Planova and Microfilters BioOptimal, its contract research org...